developing countries in Latin America?

Size: px
Start display at page:

Download "developing countries in Latin America?"

Transcription

1 . How have rotavirus vaccines worked in developing countries in Latin America? Brendan Flannery, Pan American Health Organization, Brazil and Lúcia De Oliveira, Immunization Unit/FCH, Washington, DC 9th International Rotavirus Symposium, Johannesburg, South Africa, August 2-3, 2010

2 How have rotavirus vaccines worked in developing countries in the Americas Political support Rotavirus surveillance network Disease burden and cost effectiveness Vaccine introduction Impact of vaccination Special studies Lessons learned

3 Political support

4 Pan American Health Organization s (PAHO) Regional Immunization Program Reduce inequities in health between resourcewealth and resource poor countries Political commitment, technical, operational and financial support Providing new and underutilized vaccines to the children and families who need them

5 Resolution by Ministers of Health, PAHO Directing Council meeting in 2006 Support WHO s Global Immunization Vision and Strategy and the Millennium Development Goals Resolve to mobilize additional funding to sustainably introduce new vaccines against rotavirus, pneumococcal and human papillomavirus Of 20 countries with highest under 5 mortality, 13 have introduced rotavirus vaccines Latin American countries on track to meet MDG4

6 Financing immunization programs National support for EPI: 93% is financed by governments Vaccine price, PAHO s Revolving Fund, 2009: Rotarix: US$ 7.50 /dose, $15 /child RotaTeq: US$ 5.50 /dose, $16.5 /child Rotavirus vaccine represents 97.3% of the cost of the basic immunization schedule of countries (OPV, DPT, Hib, HepB, MMR) GAVI countries: Bolivia and Honduras approved by GAVI, Guyana financed on its own

7 Rotavirus surveillance network

8 PAHO Guidelines Field guide Epidemiologic surveillance of Diarrheal diseases due to rotavirus Field guide on Introduction of New Vaccines based on WHO Guidelines

9 Countries participating in rotavirus surveillance network

10 Percent rotavirus-positive samples from children <5 hospitalized for diarrhea in participating countries, De Oliveira, Rotavirus Surveillance in Latin American and Caribbean, JID 2009

11 Seasonality of hospitalizations for rotavirus in participating countries, Northern hemisphere Southern hemisphere De Oliveira, Rotavirus Surveillance in Latin American and Caribbean, JID 2009

12 Disease burden and cost effectiveness

13 Causes of death among children <5 years in the Americas, 2008 Black et al., Lancet, 12 May 2010

14 Estimates of rotavirus disease burden in the Region of the Americas 15,000 deaths 75,000 hospitalizations 2 million clinic visits 10 million cases of rotavirus diarrhea Source: De Oliveira, Expert Rev. Vaccines, 2008

15 Cost-effectiveness Introduction of new vaccines needs to be grounded in evidence that they are cost effective: PRO-VAC: 5 years strategic plan to strengthen national capacity to make evidence-based decisions for new vaccines

16 Vaccine introduction

17 Rotavirus vaccine introduction Latin American countries : first countries to introduce rotavirus vaccine in public health sector: March 2006 in Panama As of May 2010, 14 countries and one territory had introduced rotavirus vaccine: 13 - Rotarix (GSK) 2 - RotaTeq (Merck)

18 Introduction of rotavirus vaccines in Latin America, Countries and total population <1 year Number of coun ntries Children <1 year (th housands)

19 Latin America and Caribbean countries with rotavirus vaccines into their routine schedules

20 Age in weeks at vaccination, Nicaragua and Brazil RotaTeq, Nicaragua Dose 1 Dose 2 Dose 3 Rotarix, Brazil

21 Comparison of first dose coverage for RotaTeq vs. DPT-HepB-Hib, Nicaragua, 2007 (RotaTeq introduced October 2006) Orozco et al., Uptake of rotavirus vaccine, Nicaragua, JID 2009

22 Rotavirus and DPT coverage for 8 Latin American countries, 2009 % co overage RV2/3 DTP3 Source: Country reports

23 Impact of vaccination

24 Diarrhea and rotavirus related admissions among children <5 years at seven hospitals, El Salvador, January to June,*

25 ERROR: stackunderflow OFFENDING COMMAND: ~ STACK:

Sustaining Immunization in Developing Countries: The Future We Make

Sustaining Immunization in Developing Countries: The Future We Make Sustaining Immunization in Developing Countries: The Future We Make Global Health Summit Denver, CO 29 April 211 Jon Kim Andrus, MD Deputy Director Umbrella of protection in the Americas Measles eradication

More information

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI

Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making LUCIA HELENA DE OLIVEIRA AND BARBARA JAUREGUI 2 Introduction of New Vaccines in Latin America and the Caribbean: Decision-Making

More information

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, 27 September-1 October 2010 Provisional Agenda Item 4.10

More information

Using surveillance data to monitor impact of rotavirus vaccine. Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO

Using surveillance data to monitor impact of rotavirus vaccine. Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO Using surveillance data to monitor impact of rotavirus vaccine Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO Main Topics Epidemiological surveillance of rotavirus in American Region Impact

More information

Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016

Update on Transition: the case of Honduras. Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 Update on Transition: the case of Honduras Minister Dra Yolani Batres AMRO/EURO Gavi Constituency Representative Geneva June 2016 GAVI Support for Honduras Content Honduras EPI Situation 2011-2016 Vaccination

More information

Accelerating the Introduction of Rotavirus Vaccines into GAVI-Eligible Countries

Accelerating the Introduction of Rotavirus Vaccines into GAVI-Eligible Countries Accelerating the Introduction of Rotavirus Vaccines into GAVI-Eligible Countries Investment Case for GAVI Secretariat Submitted by PATH s Rotavirus Vaccine Program in collaboration with WHO and the US

More information

144th SESSION OF THE EXECUTIVE COMMITTEE

144th SESSION OF THE EXECUTIVE COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 144th SESSION OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 22-26 June 2009 Provisional Agenda Item 4.17 CE144/22, Rev. 1 (Eng.) 11 June 2009

More information

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere,

Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 1 Introduction: Progress Toward Rubella and Congenital Rubella Syndrome Elimination in the Western Hemisphere, 2003-2008 1 Enhanced measles elimination activities in the Region of the Americas during the

More information

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, 27 September -1 October 2010 CD50/DIV/9 ORIGINAL: SPANISH

More information

Vaccines Supply Shortages Challenges & Opportunities

Vaccines Supply Shortages Challenges & Opportunities The Pan American Health Organization (PAHO) Revolving Fund for Vaccine Procurement Vaccines Supply Shortages Challenges & Opportunities Developing Country Vaccine Manufacturers Network (DCVMN) www.paho.org/immunization

More information

Can we improve the performance of live oral rotavirus vaccines?

Can we improve the performance of live oral rotavirus vaccines? Can we improve the performance of live oral rotavirus vaccines? Duncan Steele 9 th International Rotavirus Symposium 2 & 3 August 2010, Johannesburg, South Africa Vaccine efficacy against severe rotavirus

More information

52nd DIRECTING COUNCIL 65th SESSION OF THE REGIONAL COMMITTEE

52nd DIRECTING COUNCIL 65th SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 52nd DIRECTING COUNCIL 65th SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, from 30 September to 4 October 2013 Provisional Agenda Item

More information

Taking vaccine effectiveness into public health decision making: The ProVac Example

Taking vaccine effectiveness into public health decision making: The ProVac Example http://www.paho.org/provac Taking vaccine effectiveness into public health decision making: The ProVac Example Evaluating dengue effectiveness workshop June 12 th, 2014 Washington, DC Cara Bess Janusz

More information

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative

Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative http://www.paho.org/provac Strengthening evidence-based decision making for new vaccine introduction: PAHO s ProVac Initiative Cara Bess Janusz Immunization, PAHO 1 st Regional Dengue Symposium 3-4 November

More information

Global Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008

Global Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008 Global Immunization Vision and Strategies (GIVS) 2006-2015 Vaccine Tender 2010-2012, Pretender Meeting, Copenhagen 10-11 December 2008 Dr Ahmed Magan & Dr Osman David Mansoor Programme Division UNICEF

More information

Last mile vaccine distribution to rural health centres. Faheem Merchant

Last mile vaccine distribution to rural health centres. Faheem Merchant Last mile vaccine distribution to rural health centres Faheem Merchant New Global Immunization Goals 2000 - Millennium Development Goal # 4 Reduce under 5 child mortality by 2/3 between 1990 and 2015.

More information

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience

Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience Understanding the Roles of Different Bodies in Vaccine Decision Making: The Caribbean EPI Experience Prof J Peter Figueroa Department of Community Health & Psychiatry University of the West Indies Kingston,

More information

Influenza Vaccine Use In the Americas

Influenza Vaccine Use In the Americas Influenza Vaccine Use In the Americas Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-i Alba Maria Ropero-Alvarez Comprehensive Family Immunization Unit PAHO/FGL/IM Global Vaccine and

More information

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing

More information

Rotavirus vaccines: Issues not fully addressed in efficacy trials

Rotavirus vaccines: Issues not fully addressed in efficacy trials Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006

More information

Monitoring For Rotavirus Serotypes In The Americas. Jon Gentsch

Monitoring For Rotavirus Serotypes In The Americas. Jon Gentsch Monitoring For Rotavirus Serotypes In The Americas Jon Gentsch Centers for Disease Control and Prevention, Atlanta, USA * The findings and conclusions in this presentation are those of the authors and

More information

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA

Vaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA TM Vaccines against Rotavirus & Norovirus Umesh D. Parashar CDC, Atlanta, GA 1 Rotavirus is the Leading Cause Of Severe Diarrhea in Children

More information

A Briefing Paper on Rotavirus

A Briefing Paper on Rotavirus COMMON VIRUS AND SENSELESS KILLER: A Briefing Paper on Rotavirus DIARRHEA KILLS. MOTHERS IN THE WORLD S POOREST COUNTRIES KNOW THIS ALL TOO WELL. It s a fact few people in wealthier nations realize. Rotavirus

More information

Update on Pentavalent Human-Bovine Rotavirus Vaccine. Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014

Update on Pentavalent Human-Bovine Rotavirus Vaccine. Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014 Update on Pentavalent Human-Bovine Rotavirus Vaccine Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014 Outline Characteristics of RotaTeq and its worldwide use Recent data evaluating

More information

Global Health Policy: Vaccines

Global Health Policy: Vaccines Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY

More information

Value of post-licensure data to assess public health value Example of rotavirus vaccines

Value of post-licensure data to assess public health value Example of rotavirus vaccines Value of post-licensure data to assess public health value Example of rotavirus vaccines TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines

More information

Common Virus and Senseless Killer: A Briefing Paper on Rotavirus

Common Virus and Senseless Killer: A Briefing Paper on Rotavirus Common Virus and Senseless Killer: A Briefing Paper on Rotavirus Diarrhea kills. Mothers in the world s poorest countries know this all too well. It s a fact few people in wealthier nations realize. Rotavirus

More information

Alternative Rotavirus Vaccine Candidates: Why should we bother?

Alternative Rotavirus Vaccine Candidates: Why should we bother? Alternative Rotavirus Vaccine Candidates: Why should we bother? Duncan Steele Initiative for Vaccine Research, WHO 7 th International Rotavirus Symposium 12-13 June 2006, Lisboa, Portugal Rotavirus Vaccines

More information

Introduction to the ProVac Initiative

Introduction to the ProVac Initiative Introduction to the ProVac Initiative E-toolkit training module Nathalie El Omeiri, PAHO/WHO, Washington D.C. Family, Health Promotion and Life Course, Immunization unit, elomeirin@paho.org Contents of

More information

FOURTH ANNUAL VACCINATION WEEK IN THE AMERICAS (VWA 2006) FINAL REPORT

FOURTH ANNUAL VACCINATION WEEK IN THE AMERICAS (VWA 2006) FINAL REPORT Immunization Unit Community and Family Health Area FOURTH ANNUAL VACCINATION WEEK IN THE AMERICAS (VWA 2006) FINAL REPORT 22-29 April 2006 Background Vaccination Week in the Americas (VWA) is an initiative

More information

Rotavirus: WHO Global Recommendations, Policy, and Surveillance

Rotavirus: WHO Global Recommendations, Policy, and Surveillance Rotavirus: WHO Global Recommendations, Policy, and Surveillance 9 th International Rotavirus Symposium 2 August 2010 Mary Agócs, MD, MSc Department of Immunization, Vaccines & Biologicals From 1999 2009:

More information

Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia

Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia Lucia Inchauste, Nataniel Mamani, Sonia Jimenez, Raul Montesano, Maritza Patzi, Rita Revollo,

More information

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan

Championing Health: Sustainable Development and Equity. PAHO Strategic Plan Championing Health: Sustainable Development and Equity PAHO Strategic Plan 2014-2019 PAHO Strategic Plan 2014-2019 While we celebrate important achievements, we recognize that much remains to be accomplished.

More information

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007 History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we

More information

ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE [ ] THE LATEST EVIDENCE & WHAT S NEEDED TO STOP ILLNESSES AND DEATHS

ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE [ ] THE LATEST EVIDENCE & WHAT S NEEDED TO STOP ILLNESSES AND DEATHS ROTAVIRUS COMMON, SEVERE, DEVASTATING, PREVENTABLE [ ] THE LATEST EVIDENCE & WHAT S NEEDED TO STOP ILLNESSES AND DEATHS ROTACOUNCIL.ORG Table of contents Introduction...4 What is rotavirus?... 5 Vaccines:

More information

Global Vaccine Action Plan (GVAP)

Global Vaccine Action Plan (GVAP) Volume XXXV Number 1 Immunize and Protect Your Family February 2013 Global Vaccine Action Plan (GVAP) Immunization is considered one of the most effective public health interventions and is credited with

More information

Zika Operation: IMPACT IN THE AMERICAS. Americas Regional Office

Zika Operation: IMPACT IN THE AMERICAS. Americas Regional Office Zika Operation: IMPACT IN THE AMERICAS Americas Regional Office WHAT IS the Zika Operation in the Americas? The Zika Operation works to: Support National Societies in responding to the outbreak and implementing

More information

Conclusions and Recommendations of the Experts Meeting on Rotavirus Genotypes in the Region of the Americas

Conclusions and Recommendations of the Experts Meeting on Rotavirus Genotypes in the Region of the Americas Conclusions and Recommendations of the Experts Meeting on Rotavirus Genotypes in the Region of the Americas Eyal Leshem December 9, 2013 National Center for Immunization & Respiratory Diseases Division

More information

Progress Made in the Integration of EPI Costing and Planning

Progress Made in the Integration of EPI Costing and Planning Volume XXXV Number 5 Immunize and Protect Your Family October 2013 Progress Made in the Integration of EPI Costing and Planning If we compare the situation of the Expanded Program on Immunization (EPI)

More information

GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE

GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE 1 Phasing in (an early diagram) 5 year Vaccine Fund commitment extended over 8 year phase- Countries will be notified of 5 year Vaccine Fund commitment Investments

More information

Regional Immunization Action Plan for the Americas Progress report 2015

Regional Immunization Action Plan for the Americas Progress report 2015 Regional Immunization Action Plan for the Americas Progress report 2015 Introduction During the 54th Directing Council meeting of the Pan American Health Organization (PAHO) in September 2015, Member States

More information

Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services

Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services Gisele Almeida Public Policies, Regulation, and Health Financing Health Systems and Services Challenges to the Health Sector External Context Complexity of health determinants Multiplicity of initiatives

More information

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015

Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015 Overview of the First Regional Dengue Symposium Rio de Janeiro, Brazil, 3-4 November 2015 Ana F. Carvalho, MBA, MPH Director, Special Projects Vaccine Advocacy and Education Presented by: Jacqueline Lim

More information

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector

1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector 1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share

More information

HPV Vaccines: Background and Current Status

HPV Vaccines: Background and Current Status HPV Vaccines: Background and Current Status Bogota, Colombia, 2007 Jon Kim Andrus, MD HPV and Cervical Cancer Evidence that HPV is essential: Documented molecular studies of cervical cancer Case-control

More information

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE

50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 50th DIRECTING COUNCIL 62nd SESSION OF THE REGIONAL COMMITTEE Washington, D.C., USA, 27 September-1 October 2010 Agenda Item 4.17 27 September

More information

WHITE PAPER. A Summary of Global Immunization Coverage through David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order)

WHITE PAPER. A Summary of Global Immunization Coverage through David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order) WHITE PAPER A Summary of Global Immunization Coverage through 2013 David W Brown, Anthony H Burton, Marta Gacic-Dobo (alphabetical order) for the WHO and UNICEF working group for monitoring national immunization

More information

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.

Shabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. Shabir A. Madhi Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. National Institute for Communicable Diseases & University of Witwatersrand,

More information

GSK VACCINES: KEY GROWTH DRIVERS

GSK VACCINES: KEY GROWTH DRIVERS GSK VACCINES: KEY GROWTH DRIVERS Martin Andrews Senior Vice President, Global Vaccines Centre of Excellence, GSK Biologicals Millions of children die from infectious diseases Many of these deaths are preventable

More information

Disease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006

Disease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006 Disease Control Priorities and Rotavirus Presentation Vaccines Title Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006 1 What is the DCPP? DCPP is an alliance of organizations

More information

Dr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine

Dr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine Dr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases; Medical Research Council: Respiratory and

More information

THIRTY-FIRST MEETING OF THE CARIBBEAN IMMUNIZATION MANAGERS FINAL REPORT

THIRTY-FIRST MEETING OF THE CARIBBEAN IMMUNIZATION MANAGERS FINAL REPORT Comprehensive Family Immunization Unit Department of Family, Gender and Life Course THIRTY-FIRST MEETING OF THE CARIBBEAN IMMUNIZATION MANAGERS FINAL REPORT Georgetown, Guyana 17-19 November 2015 Contents

More information

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas

Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas Vaccine Hesitancy: Acceptance and demand of vaccines in the Americas Desiree Pastor, MD, MPH Regional Immunization Advisor Immunization Unit Department of Family, Gender and Life Course PAHO/WHO Outline

More information

Roger I. Glass, M.D., Ph.D. Director, Fogarty International Center Associate Director for International Research, NIH

Roger I. Glass, M.D., Ph.D. Director, Fogarty International Center Associate Director for International Research, NIH Rotavirus Vaccines: Prioritization for Introductions- National & International Case Studies Fondation Merieux Conference Center November 27, 2012 Roger I. Glass, M.D., Ph.D. Director, Fogarty International

More information

Regional Update Influenza (August 16, h GMT; 12 h EST)

Regional Update Influenza (August 16, h GMT; 12 h EST) Regional Update Influenza (August 16, 21-17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National Influenza

More information

Lessons Learned and Best Practices of Achieving and Maintaining Measles and Rubella Elimination in the Americas

Lessons Learned and Best Practices of Achieving and Maintaining Measles and Rubella Elimination in the Americas Lessons Learned and Best Practices of Achieving and Maintaining Measles and Rubella Elimination in the Americas Jon Kim Andrus, MD Deputy Director, PAHO Rome, Italy 8-10 February, 2012 Presentation Outline

More information

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD Vaccines Global impact of a preventive technology Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public

More information

Global Vaccine Action Plan

Global Vaccine Action Plan Global Vaccine Action Plan Regional reports on progress towards GVAP RVAP goals Annex to the GVAP Secretariat Annual Report 2016 World Health Organization 2016 All rights reserved. Publications of the

More information

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing

More information

Targeted Diseases and Immunization. Strategic plan

Targeted Diseases and Immunization. Strategic plan Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure

More information

From development to delivery: Decision-making for the introduction of a new vaccine

From development to delivery: Decision-making for the introduction of a new vaccine From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines

More information

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016 The Market Shaping Goal Shape markets for vaccines and other immunisation products to achieve moderate or high levels of healthy markets dynamics. Supply and Procurement Roadmap Rotavirus Vaccine Public

More information

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 ADRESSING CHALLENGES TO SUSTAINABLE NEW VACCINE INTRODUCTION: PERSPECTIVE FROM MONGOLIA N.UDVAL, MD, Sc D MINISTER OF HEALTH MONGOLIA CONTENT

More information

Dr. Bernd Benninghoff GSK Vaccines, GML Global Medical Affairs Director

Dr. Bernd Benninghoff GSK Vaccines, GML Global Medical Affairs Director ROTARIX the human rotavirus vaccine: -is applied in a 2-dose schedulecompletes the course at the earliest possible age, prevents morbidity and mortality from RV GE regardless of the circulating strains

More information

Challenges of use of cholera vaccines in Haiti and the Americas

Challenges of use of cholera vaccines in Haiti and the Americas http://www.paho.org Challenges of use of cholera vaccines in Haiti and the Americas Dr. Cuauhtémoc Ruiz Matus Comprehensive Family Immunization Program Background Topics Consultations at PAHO Challenges

More information

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD

Vaccines. Global impact of a preventive technology. Edwin J. Asturias, MD Vaccines Global impact of a preventive technology Edwin J. Asturias, MD Associate Professor of Pediatrics and Epidemiology Director for Latin America Center for Global Health, Colorado School of Public

More information

Action plan for the health sector response to viral hepatitis in the WHO European Region

Action plan for the health sector response to viral hepatitis in the WHO European Region Action plan for the health sector response to viral hepatitis in the WHO European Region Dr Antons Mozalevskis WHO Regional Office for Europe VHPB Albania Country Meeting: Tirana, 27-28 October 2016 Chronic

More information

Exercise: Estimating immunization program costs (~60 minutes)

Exercise: Estimating immunization program costs (~60 minutes) Exercise: Estimating immunization program costs (~60 minutes) Overview Information on the cost of procuring vaccines and of running national immunization program is a key factor in planning and managing

More information

Overview of the ProVac Initiative

Overview of the ProVac Initiative Overview of the ProVac Initiative Updated Dec. 2017 Goal of the ProVac Initiative Strengthen evidence-based decision making on immunization to sustain and further the public health impact of immunization

More information

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward

REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward REVELAC-i: Progress in measuring influenza vaccine effectiveness in Latin America and way forward SARInet annual meeting, Punta Cana, May 23 2017 Nathalie El Omeiri On behalf of REVELAC-i network, Alba

More information

FINAL REPORT TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE DISEASES AUGUST 2009, COSTA RICA

FINAL REPORT TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE DISEASES AUGUST 2009, COSTA RICA TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE DISEASES 24-26 AUGUST 2009, COSTA RICA FINAL REPORT XVIII TAG MEETING, COSTA RICA, 2009 DRAFT FINAL REPORT (2 SEPTEMBER) 1 TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE

More information

CD29/23 Page 2. (Eng.) EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS. Progress Report by the Director. 1. Background and Policy Basis

CD29/23 Page 2. (Eng.) EXPANDED PROGRAM ON IMMUNIZATION IN THE AMERICAS. Progress Report by the Director. 1. Background and Policy Basis directing council PAN AMERICAN HEALTH ORGANIZATION regional committee WORLD HEALTH ORGANIZATION XXIX Meeting Washington, D.C. September-October 1983 XXXV Meeting INDEXEo L I I Provisional Agenda Item 23

More information

Rotavirus Vaccines. Gagandeep Kang Christian Medical College Vellore

Rotavirus Vaccines. Gagandeep Kang Christian Medical College Vellore Rotavirus Vaccines Gagandeep Kang Christian Medical College Vellore Rotavirus disease burden Rotavirus vaccines and candidates Performance of vaccines in developed and developing countries Longitudinal

More information

Vaccine Pricing: Gavi Transitioning Countries

Vaccine Pricing: Gavi Transitioning Countries Vaccine Pricing: Gavi Transitioning Countries All prices shown in this document are Unicef awarded price per dose (in USD), per product, per supplier, per calendar year, based on multi-year supply agreements.

More information

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted

More information

30 th Caribbean Immunization Managers Meeting

30 th Caribbean Immunization Managers Meeting Volume XXXVI Number 6 Immunize and Protect Your Family December 2014 30 th Caribbean Immunization Managers Meeting 58 participants from 29 countries of the English, Dutch and French-speaking Caribbean

More information

Access to vaccination in GAVI countries and at global level

Access to vaccination in GAVI countries and at global level Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for

More information

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages

Hepatitis B and C in the Spotlight: A public health response in the Americas. Key Messages 2017 highlights Hepatitis B and C in the Spotlight: A public health response in the Americas Key Messages Regarding the national structures developed to support the response to the viral hepatitis epidemics,

More information

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN

REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN REGIONAL STRATEGY AND PLAN OF ACTION FOR CERVICAL CANCER PREVENTION AND CONTROL IN LATIN AMERICA AND THE CARIBBEAN 525 Twenty-third Street, N.W. Washington, D.C. 20037 1 2 In response to the high incidence

More information

Vaccine Decision-Making

Vaccine Decision-Making Key Points Vaccine Decision-Making * Decisions on introducing new vaccines have long-term implications for immunization costs as well as logistics systems and service delivery. The choice of vaccine presentation

More information

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011 Closing immunity gaps in older children and adults towards measles and rubella elimination: Lessons learned and challenges. Siena, Italy, May 10-11 2016 An aggressive approach for measles outbreak among

More information

Senior Management Team Meeting Target setting in Latin America

Senior Management Team Meeting Target setting in Latin America Senior Management Team Meeting Target setting in Latin America October 2006 Nancy Andrade-Castro RST Latin America Geneva/2006 For all enquiries, please contact Nancy Andrade-Castro, Acting Director for

More information

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting

Task Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting Task Force on Immunization (TFI) in Africa 14 th Annual Meeting And Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting Meeting Report Maputo, Mozambique 27 29 November 2006

More information

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 6, h GMT; 12 h EST) Regional Update Pandemic (H1N1) 29 (July 6, 21-17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National Influenza

More information

Rubella and CRS Elimination in the Americas

Rubella and CRS Elimination in the Americas Rubella and CRS Elimination in the Americas Jon Kim Andrus, MD Deputy Director, PAHO Rome, Italy 8-10 February 2012 Presentation Opportunities for a rubella elimimation initiative The impact of the initiative

More information

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY

B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY Page 7 B. PLAN OF ACTION FOR IMPLEMENTING THE GENDER EQUALITY POLICY Background 1. Member States approved the Pan American Health Organization s (PAHO) Gender Equality Policy during the 46th Directing

More information

Retrospective Analysis of Volume Guarantees in the Pentavalent and Rotavirus Vaccine Markets

Retrospective Analysis of Volume Guarantees in the Pentavalent and Rotavirus Vaccine Markets Oct. 2015 Retrospective Analysis of Volume Guarantees in the Pentavalent and Rotavirus Vaccine Markets For additional information, contact: Leslie Arney Sr. Research Associate lesarney@umich.edu 1 Contents

More information

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST)

Regional Update Pandemic (H1N1) 2009 (July 19, h GMT; 12 h EST) Regional Update Pandemic (H1N1) 9 (July 19, - 17 h GMT; 12 h EST) The information contained within this update is obtained from data provided by Ministries of Health of Member States and National Influenza

More information

Global Health Policy: Vaccines

Global Health Policy: Vaccines Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY

More information

TERMS OF REFERENCE. Regional Immunization Program. Department of Family, Gender and Life Course

TERMS OF REFERENCE. Regional Immunization Program. Department of Family, Gender and Life Course TERMS OF REFERENCE Regional Immunization Program Department of Family, Gender and Life Course 1/11/2017 TERMS OF REFERENCE Regional Immunization Program I. Description and Overall Purpose of the Evaluation

More information

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009. B. UPDATE ON THE PANDEMIC (H1N1) 2009 CD50/INF/6 (Eng.) - 7 - Annex B Background 20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus

More information

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators

Pandemic (H1N1) (August 28, h GMT; 12 h EST) Update on the qualitative indicators Regional Update Pandemic (H1N1) 29 (August 28, 29-17 h GMT; 12 h EST) Update on the qualitative indicators For Epidemiological Week 33 (EW 33), from 16 August to 22 August, 22 countries reported updated

More information

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines

Vaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines

More information

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012 Measles Containing Vaccines UNICEF Supply Division Industry Consultation Meeting 25-26 January 2012 Content Measles monovalent vaccine: Programme Updates and Procurement Overview Measles and Rubella vaccine:

More information

New Vaccines in SA. Regulatory Perspectives James Southern 2015

New Vaccines in SA. Regulatory Perspectives James Southern 2015 New Vaccines in SA Regulatory Perspectives James Southern 2015 Outline Regulatory Environment of new vaccines Clinical Trials Application procedures HIV Vaccines Other new vaccines in development Ongoing

More information

TWENTY-THIRD CARIBBEAN EPI MANAGERS MEETING FINAL REPORT

TWENTY-THIRD CARIBBEAN EPI MANAGERS MEETING FINAL REPORT Immunization Unit Family and Community Health Area TWENTY-THIRD CARIBBEAN EPI MANAGERS MEETING FINAL REPORT SURINAME 13-17 NOVEMBER 2006 TABLE OF CONTENTS Acronyms iii I. Introduction 1 II. Objectives

More information

Edwin J. Asturias, MD Department of International Health Johns Hopkins Bloomberg School of Public Health. University del Valle in Guatemala

Edwin J. Asturias, MD Department of International Health Johns Hopkins Bloomberg School of Public Health. University del Valle in Guatemala Vaccines: A Way to Achieve Better Health and Wealth in the Americas Edwin J. Asturias, MD Department of International Health Johns Hopkins Bloomberg School of Public Health And University del Valle in

More information

Introduction and overview of the program; new vaccine pipeline and prioritization process

Introduction and overview of the program; new vaccine pipeline and prioritization process Immunization for the Modern Family: Western Canada Immunization Forum 2011 Introduction and overview of the program; new vaccine pipeline and prioritization process Monika Naus, MD, MHSc, FRCPC, FACPM

More information

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization

DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American Health Organization/ World Health Organization DR. CLAUDINA E. CAYETANO REGIONAL MENTAL ADVISOR Pan-American / World Outline Facts and Figures Suicide a major Public problem Suicide in the Americas Risk and Protective factors and related interventions

More information